NEJM Evidence
Published by Massachussetts Medical Society
eISSN : 2766-5526
Abbreviation : NEJM Évid.
Aims & Scope
The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit.
NEJM Evidence expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making and does so in a way that respects the time and commitment of the practitioner.
NEJM Evidence seeks to advance clinical trial research and clinical practice by: • Publishing high-quality studies from the front lines of medical research. • Challenging the medical community to take new approaches to clinical trial design and execution that yield more powerful clinical evidence. • Sparking debate and conversation around areas of medicine where clinical decisions are made without sufficient evidence. • Engaging physicians in a more sophisticated and meaningful way with clinical evidence.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.154 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 1 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 3804 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 5 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.